Abstract
Urinary bladder cancer is a heterogeneous disease with a variety of pathologic features, cytogenetic (Verma et al., Radiographics 32:371–387, 2012). Early detection is important, since up to 47% of bladder cancer-related deaths may have been avoided (Verma et al., Radiographics 32:371–387, 2012). This chapter covers the staging conundrum.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Verma S, Rajesh A, Prasad SR, Gaitonde K, Lall CG, Mouraviev V, Aeron G, Bracken RB, Sandrasegaran K. Urinary bladder cancer: role of MR imaging. Radiographics. 2012;32(2):371–87.
Yamada Y, Kobayashi S, Isoshima S, Arima K, Sakuma H, Sugimura Y. The usefulness of diffusion-weighted magnetic resonance imaging in bladder cancer staging and functional analysis. J Cancer Res Ther. 2014;10(4):878–82.
Ohgiya Y, Suyama J, Sai S, Kawahara M, Takeyama N, Ohike N, Sasamori H, Munechika J, Saiki M, Onoda Y, Hirose M, Gokan T. Preoperative T staging of urinary bladder cancer: efficacy of stalk detection and diagnostic performance of diffusion-weighted imaging at 3T. Magn Reson Med Sci. 2014;13(3):175–81.
Daneshmand S, Ahmadi H, Huynh LN, Dobos N. Preoperative staging of invasive bladder cancer with dynamic gadolinium-enhanced magnetic resonance imaging: results from a prospective study. Urology. 2012;80(6):1313–8.
Nguyen HT, Pohar KS, Jia G, Shah ZK, Mortazavi A, Zynger DL, Wei L, Clark D, Yang X, Knopp MV. Improving bladder cancer imaging using 3-T functional dynamic contrast-enhanced magnetic resonance imaging. Investig Radiol. 2014;49(6):390–5.
Bashir U, Ahmed I, Bashir O, Azam M, Faruqui ZS, Uddin N. Diagnostic accuracy of high resolution MR imaging in local staging of bladder tumors. J Coll Physicians Surg Pak. 2014;24(5):314–7.
Zhou G, Chen X, Zhang J, Zhu J, Zong G, Wang Z. Contrast-enhanced dynamic and diffusion-weighted MR imaging at 3.0T to assess aggressiveness of bladder cancer. Eur J Radiol. 2014;83(11):2013–8.
Liedberg F, Bendahl PO, Davidsson T, Gudjonsson S, Holmer M, Månsson W, Wallengren NO. Preoperative staging of locally advanced bladder cancer before radical cystectomy using 3 tesla magnetic resonance imaging with a standardized protocol. Scand J Urol. 2013;47(2):108–12.
Maurer T, Eiber M, Krause BJ. [Molecular multimodal hybrid imaging in prostate and bladder cancer]. Urologe A. 2014a;53(4):469–83.
Jensen TK, Holt P, Gerke O, Riehmann M, Svolgaard B, Marcussen N, Bouchelouche K. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology. Scand J Urol Nephrol. 2011;45(2):122–8.
Maurer T, Horn T, Souvatzoglou M, Eiber M, Beer AJ, Heck MM, Haller B, Gschwend JE, Schwaiger M, Treiber U, Krause BJ. Prognostic value of 11C-choline PET/CT and CT for predicting survival of bladder cancer patients treated with radical cystectomy. Urol Int. 2014b;93(2):207–13.
Mertens LS, Mir MC, Scott AM, Lee ST, Fioole-Bruining A, Vegt E, Vogel WV, Manecksha R, Bolton D, Davis ID, Horenblas S, van Rhijn BW, Lawrentschuk N. 18F-Fluorodeoxyglucose—positron emission tomography/computed tomography aids staging and predicts mortality in patients with muscle-invasive bladder cancer. Urology. 2014;83(2):393–8.
Nayak B, Dogra PN, Naswa N, Kumar R. Diuretic 18F-FDG PET/CT imaging for detection and locoregional staging of urinary bladder cancer: prospective evaluation of a novel technique. Eur J Nucl Med Mol Imaging. 2013;40(3):386–93.
Kollberg P, Almquist H, Bläckberg M, Cronberg C, Garpered S, Gudjonsson S, Kleist J, Lyttkens K, Patschan O, Liedberg F. [(18)F]Fluorodeoxyglucose - positron emission tomography/computed tomography improves staging in patients with high-risk muscle-invasive bladder cancer scheduled for radical cystectomy. Scand J Urol. 2015;49(4):296–301.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2021 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Goonewardene, S.S., Ventii, K., Bahl, A., Persad, R., Motiwala, H., Albala, D. (2021). Muscle Invasive Bladder Cancer and the Staging Conundrum: Which Imaging Modality Is Best?. In: Management of Muscle Invasive Bladder Cancer. Management of Urology. Springer, Cham. https://doi.org/10.1007/978-3-030-57915-9_15
Download citation
DOI: https://doi.org/10.1007/978-3-030-57915-9_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-57914-2
Online ISBN: 978-3-030-57915-9
eBook Packages: MedicineMedicine (R0)